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H I G H L I G H T S
• Atomoxetine decreases reaction time of the most prevalent trials.
• Atomoxetine modulates the accumulation rate of sensory information.
• Atomoxetine adapts the response strategy to the context.
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A B S T R A C T
The role of norepinephrine (NE) in visuo-spatial attention remains poorly understood. Our goal was to identify
the attentional processes inﬂuenced by atomoxetine (ATX) injections, a NE-reuptake inhibitor that boosts the
level of NE in the brain, and to characterize these inﬂuences. We tested the eﬀects of ATX injections, on seven
monkeys performing a saccadic cued task in which cues and distractors were used to manipulate spatial at-
tention. We found that when the cue accurately predicted the location of the upcoming cue in 80% of the trials,
ATX consistently improved attentional orienting, as measured from reaction times (RTs). These eﬀects were best
accounted for by a faster accumulation rate in the valid trials, rather than by a change in the decision threshold.
By contrast, the eﬀect of ATX on alerting and distractor interference was more inconsistent. Finally, we also
found that, under ATX, RTs to non-cued targets were longer when these were presented separately from cued
targets. This suggests that the impact of NE on visuo-spatial attention depends on the context, such that the
adaptive changes elicited by the highly informative value of the cues in the most frequent trials were accom-
panied by a cost in the less frequent trials.
1. Introduction
Visuo-spatial attention is a pervasive function that enables us to
selectively process visual information through prioritization of a spatial
location while setting aside other locations. It depends on the fronto-
parietal network and is under the inﬂuence of several neuromodulators
including dopamine (DA), acetylcholine (ACh) and norepinephrine
(NE) (see Noudoost and Moore, 2011). While a systematic approach to
understand the role of DA and ACh in visual-spatial attention has been
carried out over the years, the role of NE is currently less understood
(see Noudoost and Moore, 2011).
In particular, only a handful of studies have addressed the role of NE
transmission in visuo-spatial attention and its sub-components
(alerting, orientating and executive control; Posner, 1980, Petersen and
Posner, 2012), and the results are inconsistent. Petersen and Posner
(2012) suggest a speciﬁc role of NE in the maintenance of high sensi-
tivity to incoming stimuli i.e. the alerting sub-component (Petersen and
Posner, 2012). At least two studies provide evidence in support of this
(Witte and Marrocco, 1997; Coull et al., 2001). Evidence of the con-
tribution of NE to spatial orienting is more inconsistent (Clark et al.,
1989; Coull et al., 2001; Witte and Marrocco, 1997). As to attentional
executive control, the third attentional sub-component, reaction times
to identical external events have been shown to be aﬀected by general
task context, and to be much faster in highly predictive contexts than in
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less predictive contexts (Los, 1996; Los et al., 2001; Albares et al., 2011;
Wardak et al., 2012). While there is, to our knowledge, no direct evi-
dence for an eﬀect of NE onto this attentional sub-component, a recent
study shows a selective increase in pupil size, an indirect index of NE
activity, in the presence of highly predictive cues (Dragone et al.,
2018). In addition, the involvement of the NE system in the ability to
shift attentional set was reported in several studies (McGaughy et al.,
2008; Newman et al., 2008; Cain et al., 2011; Berridge et al., 2012;
Bradshaw et al., 2016). This, thus, suggests a possible interaction be-
tween NE and attentional executive control.
Here, we focused onto these three speciﬁc attentional components,
namely alerting, spatial orienting and executive control and we aimed
at 1) clarifying the components that are under the inﬂuence of NE
availability and 2) characterizing the speciﬁc action of NE availability
onto them.
We thus tested seven monkeys in a saccadic cued task derived from
the attentional network task (Posner, 1980). This task allows manip-
ulating the focus of attention by using cues that precede the appearance
of the target. We used a context where the cue accurately predicted the
spatial location of the upcoming target in 80% of the trials. A distractor
could also appear simultaneously with the target to examine the sub-
jects’ ability to ﬁlter distractors out when planning their saccadic
movement. We tested the monkeys under two pharmacological condi-
tions: after saline administration used as the control condition and after
atomoxetine (ATX) administration, a NE reuptake inhibitor.
To investigate whether alerting and orienting were aﬀected by ATX,
we computed attentional network scores from the reaction times (Fan
et al., 2002). To identify changes driven by task context and executive
control, we compared RTs in same type of trial in two diﬀerent context.
To investigate how these attentional processes were aﬀected by ATX,
we used the LATER model (linear approach to threshold with ergodic
rate; Carpenter and Williams, 1995) to test whether changes in RT
distributions following NE modulation were better accounted for by a
change in signal accumulation rate, signing a perceptual process, or a
change in decision threshold, signing a top-down process (Noorani and
Carpenter, 2016). Following ATX injections, one could expect either 1)
a global non-speciﬁc eﬀect onto all three attentional components; 2) an
eﬀect speciﬁc to the alerting non-selective attentional component or 3)
an eﬀect speciﬁc to the dynamic/ﬂexible components of attention,
namely orienting and executive control. Our observations speak in
favor of the last prediction.
2. Methods
2.1. Subjects
Seven rhesus monkeys (Macaca mulatta) aged 5–14 years partici-
pated to this study, three females (monkeys CA, GU and CE) and four
males (monkeys EL, TO, HN and DO). Animals had free access to water
(CE, CA and GU) or food (EL, TO, HN and DO) and were maintained on
a food (CE, CA and GU) or water (EL, TO, HN and DO) regulation
schedule, individually optimized to maintain stable motivation and
performance. This study was conducted in strict accordance with
Directive 2010/63/UE of the European Parliament and the Council of
22 September 2010 on the protection of animals used for scientiﬁc
purposes and approved by the French Committee on the Ethics of
Experiments in Animals (C2EA) CELYNE registered at the national level
as C2EA number 42.
2.2. Experimental set-up
Monkeys were seated in a primate chair in a sphinx position, with
the head immobilized via a surgically implanted plastic MRI-compa-
tible head post (CE, TO, EL, HN, DO) or a non-invasive head restraint
helmet (CA and GU) (Hadj-Bouziane et al., 2013), in front of a com-
puter screen (distance: 57 cm for CE, CA and GU; 78 cm for EL, TO, HN
and DO). Gaze location was sampled at 120 Hz using an infrared pupil
tracking system (ISCAN Raw Eye Movement Data Acquisition Software)
interfaced with a program for stimulus delivery and experimental
control (Presentation®).
Fig. 1. Behavioral task and LATER model. A: In
the mixed runs (spatial attention cued task), mon-
keys initiated the trial by ﬁxating the red cross. Then,
a cue was ﬂashed and the monkey was required to
keep his gaze on the red cross. The cue could either
be valid, invalid, neutral or absent. After a cue-target
interval (CTI), the target appeared on one side of the
screen. Simultaneously, a distractor could appear in
the same or opposite hemiﬁeld of the target location.
The monkey had to ignore the distractor and saccade
to the new target location to successfully complete
the trial and receive a reward. The pure runs did not
include any cue nor any distractor and monkey had
to saccade to the target location to successfully
complete the trial and receive a reward. B: According
to the LATER model, RT is the culmination of a de-
cisional signal which starts at the apparition of the
target, rises in response with a constant linear rate (r)
and ends with the initiation of a response at the de-
cision threshold (θ) (left panel). Cumulative RT dis-
tributions are plotted as reciprobit plots, so that each
distribution corresponds to a line. On this plot, the
change of accumulation rate is embodied by a shift of
the lines (middle panel) and the change of the deci-
sional threshold by a swivel of the lines (right panel).
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2.3. Behavioral task
A testing session consisted of alternations of two types of runs:
mixed runs and pure runs. In both types of runs, monkeys were required
to ﬁxate a central cross to initiate the trial. Then, the target appeared
randomly in the left or right side of the screen (10 degrees of eccen-
tricity), and monkeys had to saccade as fast as possible to the target
location and hold ﬁxation during 300ms (EL, TO, HN and DO) or
500ms (GU, CA and CE) to receive a reward (fruit juice or water). In
the mixed runs, derived from the attentional network task (Posner,
1980), several conditions were intermixed, while in the pure runs, only
one condition was presented to the animals. For 4 monkeys (EL, TO, HN
and DO), the color of the central cross changed across the type of runs
(red or yellow cross for mixed and pure runs, respectively).
In the mixed runs (Fig. 1A), for 80% of the trials, a peripheral cue, a
white dot or a grey square, was ﬂashed for 100ms prior to the target
onset on one side of the screen, accurately predicting the upcoming
target location (‘valid cue’). In the remaining 20% of the trials, the cue
was either absent (‘no cue’), or presented on the opposite side of target
location (‘invalid cue’), or two cues were simultaneously presented
(‘neutral cue’). In addition, a distractor, a red circle or a red square,
could appear simultaneously with the target onset, either in the same or
in the opposite hemiﬁeld as the target (distance target-distractor: 4.5°
for GU, CA and CE and between 2.1° and 3.2° for EL, TO, HN and DO).
The ‘no distractor’, ‘same hemiﬁeld’ and ‘opposite hemiﬁeld’ conditions
were intermixed and equally distributed across trials. Monkeys were
required to ﬁxate the target and ignore the distractor. In the majority of
the animals (except CE), the cue-target interval (CTI) varied across
trials to prevent anticipatory responses. CTIs were optimized for each
monkey in order to maximize cue validity/invalidity eﬀects, which
were key in quantifying the attention orientation eﬀects (200-300-
400ms for GU and CA, 100ms for CE, 150-200-250ms for EL and TO,
200-250-300ms for HN, 140-180-240ms for DO). The pure runs did not
include any cue nor any distractor. These runs served to quantify the
eﬀect of NE on task context by comparing RTs on these trials to the
same trials performed in the mixed runs (i.e. taking place in a context in
which cued trials were most frequent). The mixed runs included ∼90
trials for monkeys CE, CA, GU, ∼150 trials for monkeys EL, TO,∼300
trials for monkey HN and ∼400 trials for monkey DO. Pure runs in-
cluded∼20 trials for monkeys CA, GU,∼50 trials for monkeys EL, TO,
∼100 trials for monkey HN and∼150 trials for monkey DO. Note that
only mixed runs were presented to monkey CE.
The overall structure of the task was similar for all animals. Only the
physical characteristics of the stimuli (cues, target and distractors) and
the timings varied across animals depending on their previous experi-
ence with the task and their overt behavior (Fig. 1A).
2.4. Drug administration
Once the animals reached stable performance and were accustomed
to intramuscular injections, atomoxetine (ATX, Tocris Bioscience,
Ellisville, MO) and saline (control) administration sessions began. As
shown in previous studies (Bymaster et al., 2002; Koda et al., 2010),
ATX is a potent NE reuptake inhibitor. In prefrontal cortex of mice,
injection of 1mg/kg of ATX induced a signiﬁcant increase of the ex-
tracellular levels of NE and DA. Yet, the concentration of NE was 4
times larger than that of DA. Based on previous studies conducted in
monkeys (in particular Gamo et al. 2010,) we chose the smallest eﬃ-
cient doses that corresponded to the recommended doses by the U.S.
Food and Drug Administration in children with attention deﬁcits
(0.5–1.2 mg/kg). Each experiment started with one or two weeks of
saline administration, followed by 3–4 weeks of testing with diﬀerent
doses of ATX: 0,1mg/kg, 0,5 mg/kg, 1mg/kg and 1,5mg/kg. For a
given week, the same dose of ATX was administered every day to the
animals. Note that the dose of 1,5 mg/kg was tested only in the two
younger monkeys (GU and CA). ATX or saline was administered
intramuscularly 30min prior to testing (Gamo et al., 2010). In total, for
each animal, we collected 4 to 6 sessions with each dose of ATX and 1 to
5 sessions of saline condition.
2.5. Data analysis
The data were analyzed separately for each monkey. Eye move-
ments were visually inspected with a customized toolbox implemented
in MATLAB.
2.5.1. Pupil diameter
We computed the averaged normalized pupil diameter, in the trial
initiation period (500ms before the cue onset), for each animal and
each pharmacological condition. In each trial, the mean pupil diameter
across this 500ms window was divided by the root mean square se-
parately for each animal. These measures were compared across runs
and pharmacological conditions.
2.5.2. Number of trials
We examined the number of initiated trials (i.e. Fig. 1A: completion
of the ﬁrst step: initiation) and the number of correct trials. A trial was
considered correct after the animal reached and ﬁxated the correct
target location within the imparted time (270ms for DO, 300ms for EL
and HN, 350ms for TO or 500ms for CA, GU and CE). Incorrect trials
corresponded to either incomplete trials, anticipations (RT < 80ms),
saccades with artifacts related to blink or trials where saccades were
made to the wrong target location or to the distractor location.
2.5.3. Reaction times (RTs)
2.5.3.1. Attentional scores in mixed runs. To assess the eﬀect of cues and
distractors on RTs in mixed runs, we computed four scores derived from
the attentional network scores (Fan et al., 2002) and integrating the
eﬀect of distractors (Walker and Benson, 2013): alerting score,
orienting score, remote distractor score and proximal distractor score.
Given that these diﬀerent conditions were randomly presented within
runs, these scores were calculated for each run. Runs where the number
of trials per cue type was under-represented (i.e. less than 3 trials) were
excluded.
=
−
×Orienting score RT median RT
median RT| |
100valid invalid
invalid
=
−
×Alerting score RT median RT
median RT| |
100neutral nocue
nocue
= ×
−Remote distractor score 100RT median RTmedian RT| |
different hemifield no distractor
no distractor
=
−
×Proximal distractor score
RT median RT
median RT| |
100same hemifield no distractor
no distractor
2.5.3.2. RT distributions in mixed runs. We used the LATER model
(linear Approach to Threshold with Ergodic Rate) to examine changes
in RT distribution for each attentional process (Noorani and Carpenter,
2016). This model proposes that RT is the culmination of a decisional
process which starts at the onset of the target, rises in response with a
constant linear rate (r) and ends with the initiation of a response at the
decision threshold (θ) (Fig. 1B left panel). According to this model, a
change in RT distribution can be explained by a change in the
accumulation rate or in the decision threshold. Cumulative RT
distributions are plotted as reciprobit plots, so that each distribution
corresponds to a line. On this plot, the change of accumulation rate is
embodied by a shift of the lines and the change of the decision
threshold by a swivel between them (Fig. 1B right panel). To
characterize how RT distribution was aﬀected by trial type (i.e. to
characterize a given attentional process or NE eﬀect), we calculated the
log likelihood ratio that the diﬀerence between one RT distribution and
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the other is accounted for by a shift or by a swivel. A negative log
likelihood ratio represents a change in accumulation rate between the
two distributions (i.e. a shift) and a positive log likelihood ratio
represents a change in decisional threshold (i.e. a swivel).
2.5.3.3. Non-cued trials in pure versus mixed runs. We compared RTs of
correct trials in non-cued trials presented in the pure and in the mixed
runs. We also used the LATER model to examine the changes in RT
distribution between the types of runs.
2.6. Statistical analysis
First, we used one-sample t-test to determine whether the changes in
the attentional scores diﬀered signiﬁcantly from 0 in the saline condi-
tion, i.e. to determine the inﬂuence of the diﬀerent cues and distractors
condition in the saline condition. Then, we used linear mixed models
(using the ‘lme4’ package for R, Bates et al., 2014) to examine the eﬀect
of ATX on the diﬀerent variables computed above, for each monkey. As
a ﬁrst step, we deﬁned a model containing the most appropriate
random eﬀects (i.e. factors of non-interest). Random eﬀects were thus
introduced sequentially, and their eﬀect on model ﬁt was assessed
through Likelihood Ratio Tests (LRT): residuals of each model were
compared, and the one with signiﬁcantly lower deviance as assessed by
a chi-squared test was chosen (Table 1). We then tested the eﬀect of
pharmacological condition as ﬁxed factor to evaluate the eﬀect of ATX
on pupil diameter, number of initiated and correct trials and the dif-
ferent attentional scores. To evaluate the eﬀect of ATX on RTs in the
diﬀerent cue conditions, we tested the eﬀect of pharmacological con-
dition and cue condition as ﬁxed factors. Finally, post-hoc comparisons
were carried out using pairwise comparisons through the ‘lsmeans’
package for R (p-adjusted with false discovery rate method, Lenth,
2016) to assess the eﬀect of the diﬀerent doses of ATX (and the diﬀerent
cue conditions when assessing their eﬀects on RTs).
In order to assess the relationship between the eﬀect of ATX on
pupil diameter (mean normalized pupil diameter) and on the diﬀerent
attentional scores, we computed the diﬀerence in pupil diameter and in
attentional scores between saline and ATX conditions (for highest dose
of ATX, i.e. 1.0 mg/kg for monkeys CE, EL, TO, HN, DO and 1.5 mg/kg
for monkeys GU and CA). We then tested the relationship between these
two variables using a Spearman's correlation test.
To determine whether a particular strategy was used between the
diﬀerent conditions (diﬀerent cue conditions, distractor conditions or
types of runs), LATER model log likelihood ratio tests were performed
for each subject. To evaluate the eﬀect of ATX on the strategy, we
performed a wilcoxon non-parametric paired test on the group of sub-
jects.
3. Results
In the results section below, the ATX dose-response curves are
provided for pupil diameter (Fig. 2) and attentional orienting eﬀect
(Fig. 3). Other results are detailed for the highest, and most eﬀective,
dose of ATX (1.0 mg/kg for monkeys CE, EL, TO, HN, DO and 1.5 mg/kg
for monkeys GU and CA).
3.1. Eﬀect of ATX in the mixed runs
3.1.1. ATX eﬀect on pupil size (Fig. 2)
We found a signiﬁcant main eﬀect of pharmacological condition on
pupil diameter in all monkeys (χ2(4)= 12675, p < 0.001 for GU;
χ2(4) = 10196, p < 0.001 for CA; χ2(3) = 9231.8, p < 0.001 for CE;
χ2(3) = 14905, p < 0.001 for EL; χ2(3)= 2838, p < 0.001 for TO;
χ2(3) = 47527, p < 0.001 for HN; χ2(3)= 18776, p < 0.001 for DO).
For all monkeys except DO, the highest dose of ATX increased the pupil
diameter compared to the saline condition (|z|= -94.3, p < 0.001 for
GU, |z|= -71.6, p < 0.001 for CA, |z|= -60.7, p < 0.001 for CE, Ta
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|z|= -107, p < 0.001 for EL, |z|= -146.4, p= 0.015 for TO, |z|= -
182.5, p < 0.001 for HN). For DO, the highest dose of ATX (1.0mg/kg)
signiﬁcantly decreased the pupil diameter compared to the saline
condition (|z|= 76.8, p < 0.001).
3.1.2. ATX eﬀect on attentional scores (Table 2)
As predicted (Posner, 1980), in the saline condition, 5 out of 7
monkeys exhibited a signiﬁcant alerting eﬀect, i.e. shorter RTs in
neutral trials compared to non-cued trials, and a signiﬁcant orienting
eﬀect, i.e. shorter RTs in valid trials compared to invalid trials (alerting
eﬀect: t(808)= 5.6, p= 0.002 for CE, t(155)= 12.3, p < 0.001 for EL,
Table 2
Attentional scores in mixed runs for the highest dose of ATX (1.0 mg/kg for CE, EL, TO, HN, DO and 1.5 mg/kg for GU and CA). p-values reﬂects pairwise
comparisons between the saline and the highest dose of ATX with corrections for multiple comparisons. *: signiﬁcant eﬀect in the saline condition (p< 0.05). or : signiﬁcant
increase or decrease, respectively, after ATX administration. -: no diﬀerence between saline and ATX conditions. Overall, ATX modulates all attentional scores but the most
consistent eﬀect was found for the orienting score.
Monkeys Alerting score Orienting score Remote distractor score Proximal distractor score
Saline ATX p value ATX eﬀect saline ATX p value ATX eﬀect saline ATX p value ATX eﬀect saline ATX p value ATX eﬀect
GU −4.2 −2.7 – – −6.2* 6.6 < 0.001 −12.7* −11.4 0.17 – 3.18* 1.8 – –
CA −3.4 −4.5 – – −4.5* 3 < 0.001 −7.5* −5.5 0.04 1 −0.4 – –
CE 6.4* 14 0.05 – 3.3* 8.9 < 0.001 −3.1* −8.4 <0.001 15.8* 12.6 < 0.001
EL 19.1* 24.7 0.003 31.7* 34.8 < 0.001 −16.5* −22.9 <0.001 −4.7* −14.1 < 0.001
TO 5.5* 2.9 0.007 4.3* 6.7 0.015 −2.3* −1.4 – –
–
2.4* 3.4 – –
HN 24.7* 28.5 0.21 – 38.2* 40.3 < 0.001 −14.7* −14.3 – −10.3* −13.2 0.005
DO 27.5* 23.2 0.02 9.9* −0.3 < 0.001 −4.5* −3.4 0.56 – −2.9* −3 0.79 –
Fig. 2. ATX eﬀect on pupil size. For each animal and each pharmacological
condition, we computed normalized averaged pupil diameter (mean ± s.e)
during the initiation period (ﬁxation cross). ATX signiﬁcantly increased pupil
diameter as a function of the dose, in most of the monkeys, during the initiation
period. ***:p-value < 0.001.
Fig. 3. ATX eﬀect on attentional orienting. A: For each animal and each
pharmacological condition, we computed the normalized averaged orienting
scores across runs in the diﬀerent pharmacological conditions (mean ± s.e).
Our results show that ATX enhanced the orienting score in most monkeys. *:p-
value < 0.05; **:p-value < 0.01; ***:p-value < 0.001. B: For each animal, we
computed the eﬀect of ATX on pupil diameter and on the orienting score as the
diﬀerence between saline and ATX conditions (highest dose of ATX, i.e. 1.0 mg/
kg for monkeys CE, EL, TO, HN, DO and 1.5 mg/kg for monkeys GU and CA).
Our results show that ATX-mediated changes in pupil diameter tended to be
correlated with changes in attentional orienting scores.
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t(179)= 8.5, p < 0.001 for TO, t(173) = 20.7, p < 0.001 for HN,
t(380)= 33.5, p < 0.001 for DO - orienting eﬀect: t(808)= 5.6,
p < 0.001 for CE, t(1363)= 71.8, p < 0.001 for EL, t(1693)= 15.2,
p < 0.001 for TO, t(1999) = 103.9, p < 0.001 for HN, t(4850)= 36.8,
p < 0.001 for DO). For all monkeys, the remote distractor led to longer
RTs (t(290) = -10.9, p < 0.001 for GU, t(205) = -5.9, p < 0.001 for CA,
t(331)= -4.3, p < 0.001 for CE, t(432)= -13, p < 0.001 for EL,
t(557)= -4.8, p < 0.001 for TO, t(596)= -11.2, p < 0.001 for HN,
t(1426) = -7.8, p < 0.001 for DO) whereas the proximal distractor had
diﬀerent eﬀects depending on monkeys. The proximal distractor either
reduced RTs (t(291)= 3.8, p < 0.001 for GU, t(342)= 24.2, p < 0.001
for CE, t(558)= 5.1, p < 0.001 for TO) or increased RTs (t(523)= -4.7,
p < 0.001 for EL, t(652) = -8.1, p < 0.001 for HN, t(1502)= -5.3,
p < 0.001 for DO).
ATX diﬀerentially modulated these attentional scores. Table 2
summarizes the eﬀect of the highest dose of ATX (1.0mg/kg for mon-
keys CE, EL, TO, HN, DO and 1.5mg/kg for monkeys GU and CA).
Speciﬁcally, ATX more consistently aﬀected the orienting process as
compared to the alerting and distractor ﬁltering processes (see also
Fig. 3A). Indeed, ATX injection signiﬁcantly modiﬁed the orienting
scores in all monkeys (χ2(4)= 383.5, p < 0.001 for GU, χ2(4)= 166.9,
p < 0.001 for CA, χ2(3) = 49, p < 0.001 for CE, χ2(3)= 39.7,
p < 0.001 for EL, χ2(3) = 61.7, p < 0.001 for TO, χ2(3)= 305.5,
p < 0.001 for HN, χ2(3) = 1771.1, p < 0.001 for DO) regardless of the
pattern observed in the saline condition. Post-hoc tests revealed that
ATX enhanced the orienting eﬀect in 6 out of 7 monkeys (|z|= -14,
p < 0.001 for GU, |z|= -8.1, p < 0.001 for CA, |z|= -3.8, p < 0.001
for CE, |z|= -3.4, p < 0.001 for EL, |z|= -2.5, p= 0.015 for TO,
|z|= -2.1, p < 0.001 for HN). The enhancement of the orienting eﬀect
increased as a function of the ATX dose in 5 out of 7 monkeys (Fig. 3A).
One monkey (monkey DO) had a reversed modulation, the orienting
eﬀect decreasing as a function of the ATX dose (|z|= 10.7, p < 0.001).
By comparison, our results showed that ATX either decreased or in-
creased the alerting scores and the remote or proximal distractor scores
depending on the animal. Moreover, as illustrated in Fig. 3B, the eﬀect
of ATX on pupil diameter tended to be correlated with the eﬀect of ATX
on attentional orienting (p= 0.066, r= 0.75) but not with the other
attentional scores (alerting scores: p= 0.66, r= 0.21; remote distractor
scores: p= 0.26, r= 0.5; proximal distractor scores: p= 0.96,
r=−0.3).
3.1.3. ATX eﬀect on attentional orienting
The most consistent eﬀect of ATX on the attentional scores across
animals was an improvement of the orienting eﬀect, i.e. shorter RTs on
valid than on invalid trials. To identify whether this was driven by a
change in sensory accumulation or a change in decision threshold, we
compared the response strategy, as assessed from RT distributions, in
the saline and ATX conditions, using the LATER model. In the saline
condition, in 3 out of the 5 animals exhibiting an orienting eﬀect, this
eﬀect resulted from a lower decisional threshold in the valid compared
Fig. 4. ATX eﬀect on RTs in valid and invalid trials for the highest dose of ATX (1.0 mg/kg for CE, EL, TO, HN, DO and 1.5mg/kg for GU and CA). A: For each
animal and each pharmacological condition, we computed the normalized RTs in valid (left panel) and invalid (right panel) trials across runs (mean ± s.e) by
dividing RTs by the root mean square separately for each type of trial (valid and invalid) and each monkey. B: Example of reciprobit plot in valid and invalid trials in
the saline and ATX conditions for monkey EL. **:p-value < 0.01; ***:p-value < 0.001.
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to the invalid trials (Log likelihood (LL): 2365.5, Log likelihood ratio
(LLR): 65.950, p < 0.001 for EL, LL: 3294.1, LLR: 23.693, p < 0.001
for HN and LL: 6725.6, LLR: 15.692, p < 0.001, for DO). The two other
monkeys did not exhibit any speciﬁc strategy. Under ATX, in all animals
except monkey DO, the improvement of the orienting eﬀect corre-
sponded to a reinforcement of this decision threshold-based strategy in
valid compared to invalid trials (|z|= 2.201, p=0.028). For the one
animal whose orienting score was signiﬁcantly deteriorated under ATX
(monkey DO), ATX induced the opposite eﬀect, i.e. a switch in the
strategy, from a change in the decisional threshold in the saline con-
dition (LL: 6725.6, LLR: 15.692, p < 0.001) toward a change of the
accumulation rate in the ATX condition (LL: 9508, LLR: −11.55,
p < 0.001).
The enhancement of the orienting eﬀect under ATX could result
from faster RTs in both valid and invalid trials. Alternatively, it could be
that ATX aﬀects in only one type of trials. We thus examined the eﬀect
of ATX on the RTs in valid and invalid trials. All animals, with the
exception of EL, exhibited a signiﬁcant two-way interaction between
pharmacological conditions (Saline and 3 or 4 doses of ATX) and cue
type (Valid, Invalid, Neutral and No cue) (χ2(8) = 41.6, p < 0.001 for
GU, χ2(8) = 28.3, p < 0.001 for CA, χ2(9) = 70.9, p < 0.001 for CE,
χ2(6) = 29.8, p < 0.001 for TO, χ2(6)= 87.2, p < 0.001 for HN,
χ2() = 106.3, p < 0.001 for DO, and χ2(6) = 7.9, p= 0.25 for EL). As
shown in Fig. 4A, for the majority of monkeys, this eﬀect was driven by
shorter RTs in the valid trials (|z|= 11.2, p < 0.001 for GU, |z|= 9.6,
p < 0.001 for CA, |z|= 21.8, p < 0.001 for CE, |z|= 8.3, p < 0.001
for TO, |z|= 6.5, p < 0.001 for EL). RTs in the invalid trials were only
marginally aﬀected by ATX. The analysis of the RT distributions with
the LATER model further demonstrated a faster accumulation rate for
the valid trials in the ATX condition compared to the saline condition
for 4 monkeys (LL: 4150.2, LLR: −3.246, p 0.039, for EL, LL: 15148,
LLR: −3.763, p < 0.023 for DO, LL: 4777, LLR: −6.116, p < 0.002
for GU and LL: 5053, LLR:−5.299, p < 0.005 for CA, data not shown).
For the invalid trials, ATX had no systematic impact on the RT dis-
tributions. This eﬀect is exempliﬁed in Fig. 4B for monkey EL. Overall,
this indicates that the improvement of orienting induced by ATX in-
jection is driven by faster accumulation rates following the presentation
of a valid cue as compared to the saline condition.
3.2. Pure versus mixed runs: ATX enhances task context eﬀects
3.2.1. ATX eﬀect on number of trials
Table 3 summarizes the eﬀect of the highest dose of ATX (1.0 mg/kg
for monkeys CE, EL, TO, HN, DO and 1.5 mg/kg for monkeys GU and
CA) on animals’ performance in pure and mixed runs. For 3 out of 7
monkeys, ATX increased the number of initiated trials in both types of
runs (mixed runs: |z|= -15.4, p < 0.001 for GU, |z|= -17.6,
p < 0.001 for CA, |z|= -2.7, p= 0.04 for EL; pure runs: |z|= -8.9,
p < 0.001 for GU, |z|= -2.6, p= 0.02 for CA, |z|= -2.8, p= 0.01 for
EL). By contrast, it increased the number of correct trials in only one
animal (|z|= -4.3, p= 0.001 for TO) in the pure runs compared to 5 in
the mixed runs (|z|= -3.5, p= 0.001 for CA, |z|= 0.4, p= 0.004 for
EL, |z|= -7.8, p < 0.001 for TO, |z|= -5.6, p < 0.001 for HN, |z|= -
10.5, p < 0.001for DO). In other words, ATX equally increased the
number of initiated trials in half of the animals in both mixed and pure
runs while its eﬀect on accuracy, measured as the number of correct
trials, was more pronounced in the mixed runs as compared to the pure
runs.
3.2.2. ATX eﬀect on RTs
We then focused on RTs on the non-cued trials in the pure versus the
mixed runs (Table 3, Fig. 5A). We found that ATX increased RTs in pure
runs in the majority of monkeys (|z|= -4.5, p < 0.001 for EL, |z|= -
4.9, p < 0.001 for TO, |z|= -13.1, p < 0.001 for HN, |z|= -21.6,
p < 0.001for DO), whereas its eﬀect was subtler in mixed runs where
it increased RTs in only two animals (|z|= -3.1, p= 0.01 for EL, |z|= -
8.1, p < 0.001 for DO). The analysis of the RT distributions with the
LATER model further demonstrated a slower accumulation rate in the
pure ATX runs compared to the pure saline runs for 3 monkeys (LL:
4561.2, LLR: −88.993, p < 0.001 for EL, LL: 15730.7, LLR: −9.599,
p < 0.001 DO and LL: 10253, LLR:−3.412, p < 0.033 HN) as well as
compared to the mixed ATX runs for 3 monkeys (LL: 4561.2, LLR:
−88.993, p < 0.001 for EL, LL: 7404.9, LLR: −168.680, p < 0.001
for HN and LL: 11252.8, LLR:−12.273, p < 0.001 for DO). This eﬀect
is exempliﬁed in Fig. 5B for monkey EL.
4. Discussion
We tested the impact of ATX, a NE reuptake inhibitor that increases
NE availability in the brain, on visuo-spatial attention, in seven mon-
keys performing a predictive saccadic cued task. We report two new
ﬁndings. First, we found that ATX diﬀerentially impacted the three
attentional scores measured in the mixed runs, namely alerting, or-
ienting and the distractor interference eﬀects, most consistently im-
proving the orienting process across the animals. Second, we found that
the animals were slower to detect non-cued targets, speciﬁcally in pure
runs, in the ATX compared to the saline condition. Our results suggest
that the NE inﬂuences speciﬁc processes of visuo-spatial attention, and
that this inﬂuence depends on the context.
4.1. Boosting NE transmission most consistently modulates attentional
orienting in a predictive context
We assessed the impact of ATX on attentional processes in mixed
runs. In these runs, the cue accurately predicted the upcoming target
location in 80% of the trials rendering the context highly predictive. We
found that ATX aﬀected, though not equally, all attentional processes
tested in the present work, namely alerting, orienting and the distractor
interference eﬀect. Speciﬁcally, ATX changed, in a dose-dependent
manner, the orienting process in all animals; deterioration did occur (1/
7 monkeys), but the typical eﬀect was an improvement (6/7 monkeys).
Diﬀerence in behavioral responses to ATX between individuals has been
previously reported. Such diﬀerence could reﬂect genetic determinants
diﬀerences, in particular in a NE transporter gene (Kim et al., 2006;
Greene et al., 2009; Hart et al., 2012; Whelan et al., 2012), or could be
due to variability in neuronal and synaptic properties in response to
neuromodulators (Hamood and Marder, 2014). The ATX-dependent
improvement of the orienting process resulted from faster RTs in the
trials where the cue accurately predicted the location of the target
(valid trials), i.e. the most prevalent trials in our task. This result is in
line with two previous studies that reported that clonidine, which de-
creases NE transmission, attenuated the orienting process in humans
(Coull et al., 2001; Clark et al., 1989) in a predictive context. In another
study, Witte and Marrocco, (1997) failed to reveal such an eﬀect using a
task in which valid trials constituted 57% of the total trials, i.e. in a
task, in which the spatial cues were much less predictive than in the
present study or the Coull et al. (2001) and Clark et al. (1989) studies.
As a result, in the absence of a highly predictive context, monkeys
probably had to rely more heavily on stimulus-driven processes as op-
posed to both stimulus-driven and goal-directed processes elicited by
informative peripheral cues (Chica et al., 2014). This suggests that the
impact of NE modulating agents might depend on the predictability of
the cue and in more general terms on the context. In line with this idea,
a recent study reported larger diameter of the pupil, often considered as
a proxy of the LC-NE activity, in highly predictive contexts (in which
the cue accurately predicted the location of the upcoming target in 80%
of the trials) as compared to none predictive contexts (50%, chance
level, Dragone et al., 2018). Our results also show that ATX modulated
pupil diameter in a dose-dependent manner as found by Larsen and
Waters (2018). Interestingly, the eﬀect of ATX on pupil diameter tended
to be correlated with the improvement (or deterioration for monkey
DO) in attentional orienting and not with the other attentional scores,
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which suggest a link between pupil size and attentional orienting. This
result nicely ﬁts with previous reports revealing a link between pupil
diameter and cognitive load or attentional performance (Murphy et al.,
2014; Brink et al., 2016; Irons et al., 2017). All these results suggest that
the impact of a boost in NE availability on visuo-spatial attention can be
predicted from the pupil size and might depend on the level of pre-
diction provided by the context. This eﬀect might be more pronounced
when attentional orienting involves highly informative and reliable
cues.
In addition, our results show a diﬀerent eﬀect of ATX in pure versus
mixed runs, the former being devoid of spatial cues and distractors as
opposed to the latter one. First, ATX more consistently aﬀected the rate
of success (i.e. number of correct trials) across animals in the mixed
runs compared to the pure runs. Second, when focusing on the non-
cued trials in both types of runs, it appears that ATX more consistently
increased RTs for these trials in pure runs while it only marginally af-
fected RTs for these particular trials in mixed runs. In our experimental
design, the monkeys performed about 3 times more mixed runs trials
compared to pure runs trials. It is thus possible that the impact of ATX
on performance was biased toward the most prevalent type of runs (i.e.
mixed runs) and more speciﬁcally toward the most prevalent type of
trials (i.e. valid trials that represented 80% of the trials, with a spatial
cue accurately predicting the location of the target). At the time of
testing, all the animals had extensive experience with the task and the
alternations between the pure and mixed runs. We thus suggest that the
diﬀerence of ATX eﬀect on pure versus mixed runs might be interpreted
in terms of a trade-oﬀ in performance that depended on the context.
This ﬁnding is in line with the idea that the LC-NE system facilitates the
mobilization of sensory and attentional resources to process informa-
tion of the environment (Varazzani et al., 2015) and to provide beha-
vioral ﬂexibility, notably in the ability to shift attentional set (Lapiz and
Morilak, 2006; McGaughy et al., 2008; Newman et al., 2008; Seu et al.,
2009; Cain et al., 2011; Bradshaw et al., 2016). NE-dependent im-
provement in performance has been reported in other tasks involving
working memory (Gamo et al., 2010), cognitive control (Faraone et al.,
2005), sustained attention (Berridge et al., 2012) or sensory dis-
crimination (Gelbard-sagiv et al., 2018). Our results further suggest
that, beyond a global adjustment of the behavior to the context, ATX
Table 3
Number of trials and RTs to non-cued targets in mixed and pure runs for the highest dose of ATX (1.0 mg/kg for CE, EL, TO, HN, DO and 1.5mg/kg for GU and
CA). or : signiﬁcant increase or decrease, respectively, after ATX administration. -: no diﬀerence between saline and ATX conditions. NA: not applicable, note that CE did
not perform the pure run condition. Overall, ATX tended to increase the number of initiated trials in both types of runs while it tended to improve accuracy only in
mixed runs. In addition, ATX increased RTs in pure runs in the majority of monkeys whereas its eﬀect on RTs was subtler in mixed runs.
Monkeys Number of initiated trials
pure runs mixed runs ATX Eﬀect
saline ATX P values saline ATX P values pure runs mixed runs
GU 167 283 <0.001 1067 1663 <0.001
CA 122 381 0.01 813 1846 <0.001
CE NA NA NA 1113 2240 <0.001 NA
EL 1048 1528 0.01 3323 4225 0.04
TO 1095 1208 – 3531 4742 0.99 – –
HN 1504 3058 <0.001 3757 6435 – –
DO 3459 3898 – 8820 11678 <0.001 – –
Monkeys Number of correct trials
pure runs mixed runs ATX Eﬀect
saline ATX P values saline ATX P values pure runs mixed runs
GU 166 278 0.45 1002 1514 0.31 – –
CA 116 359 – 755 1781 0.001 –
CE NA NA NA 1070 1618 <0.001 NA
EL 710 697 <0.001 1980 2283 0.004
TO 760 966 <0.001 2271 3352 <0.001
HN 1176 2054 <0.001 2601 4697 <0.001
DO 2917 3232 0.09 6418 8938 <0.001 –
Monkeys RT (ms) in no cued trials (mean RT ± S.E.)
pure runs mixed runs ATX Eﬀect
saline ATX P values saline ATX P values pure runs mixed runs
GU 156
±1.4
158
±1.2
0.32 165.5
± 2.9
163.1
± 2
0.54 – –
CA 201
±3.7
198
±1.7
0.36 203.7
± 5.7
208.5
± 3.1
– – –
CE NA NA NA 231.2
± 4.5
212.8
± 5.5
0.06 NA –
EL 226.2
±1.2
245.8
±1.1
< 0.001 231.5
± 2.3
240.7
± 1.3
0.01
TO 243.2
±1.2
244.4
±1
<0.001 261.1
± 2.4
259.9
± 2
– –
HN 225.1
±1.3
244.2
±1
<0.001 245.9
± 1.9
246
±1.5
– –
DO 217.9
±0.4
231.6
±0.4
< 0.001 227.6
± 1
236.6
± 0.7
< 0.001
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ﬁne-tunes the behavior at the level of the trial to maximize reward rate,
leading to a trade-oﬀ in the infrequent trials (Aston-Jones and Cohen,
2005; Bouret and Sara, 2005; Corbetta et al., 2008; Fazlali et al., 2016).
Thus, to answer our ﬁrst question as to which components of visuo-
spatial attention are under the inﬂuence of NE availability, our results
points towards a speciﬁc eﬀect onto the dynamic and ﬂexible compo-
nents of attention, namely spatial orienting and executive control when
the context is highly predictive. Note that the eﬀect of ATX, at the
highest dose used in the present study, might have also inﬂuenced the
dopamine transmission in the brain and in particular in the prefrontal
cortex (Bymaster et al., 2002; Upadhyaya et al., 2013). At this stage,
one cannot rule out this possibility and future studies should tackle this
diﬃcult challenge to tease apart the speciﬁcity of each of these two
major neuromodulators onto attentional processes.
4.2. ATX-boosting eﬀect on spatial orienting reﬂects changes on both
sensory accumulation rate and decision threshold
The detection of a target involves both a perceptual process that can
be modelled by an accumulation of information, and a decision-making
step more related to top-down processes, that can be modelled by the
application of a decision threshold (Noorani and Carpenter, 2016).
Thus, in addition to measuring the impact of ATX on attentional scores
using median reaction times, we also sought to identify ATX-driven
variations in accumulation rate and decision threshold by comparing
RT distributions using LATER model statistics. First, the LATER model
revealed that the adaptation to the context observed under ATX con-
dition, highlighted by a speciﬁc improvement of attentional orienting,
is explained by a lower decisional threshold in ATX condition compared
to saline condition. Second, we found a faster accumulation rate spe-
ciﬁcally for the trials in which the target was preceded by a predictive
spatial cue (validly cued trials) under ATX with respect to saline. In
other words, under high NE availability, monkeys both accumulated the
available sensory evidence faster and needed less sensory information
to take their decision to saccade toward the target, speciﬁcally in the
prevalent valid trials. On the contrary, we observed a slower accumu-
lation rate in the ATX condition compared to the saline condition in the
pure runs. This ﬁnding is in line with an increasing number of studies
showing that NE inﬂuences bottom-up processes, even at very early-
stages of sensory signal processing improving the signal-noise ratio in
sensory cortex in response to incoming stimuli, to shape the behavior
according to the environment (see Navarra and Waterhouse, 2018;
Waterhouse and Navarra, 2018). For example, it has been shown that
following a systemic injection of ATX, neuronal responses to light sti-
muli was enhanced in dorsal lateral geniculate nucleus (i.e. the primary
sensory relay for visual information from the retina to the visual cortex)
in anesthetized rats (Navarra et al., 2013). A recent study showed that
manipulating the NE level in humans modulates the perceptual sensi-
tivity to detect a visual target and this eﬀect reﬂected changes in
evoked potentials and fMRI signals in visual cortex (Gelbard-sagiv
Fig. 5. ATX eﬀect on RTs in non-cued trials in mixed and pure runs for the highest dose of ATX (1.0 mg/kg for CE, EL, TO, HN, DO and 1.5 mg/kg for GU and
CA). A: For each animal and each pharmacological condition, we computed the normalized RTs in non-cued trials in mixed (left panel) and pure (right panel) runs
across runs (mean ± s.e) by dividing RTs by the root mean square separately for each type of runs (pure and mixed) and each monkey. B: Example of reciprobit plot
in non-cued trials in mixed and pure runs in the saline and ATX conditions for monkey EL. *:p-value < 0.05; ***:p-value < 0.001.
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et al., 2018). At rest, ATX was also found to reduce the functional
correlation strength within sensory networks and to modify the func-
tional connectivity between the LC and the fronto-parietal attention
network (Guedj et al., 2016, 2017), involved in visuo-spatial orienting
(Corbetta et al., 2008).
Thus, to get to our second aim that was to characterize the action of
NE availability onto the visuo-spatial components, our results points
toward two complementary actions of NE, on both bottom-up and top-
down processes. Our results bring new evidence to the role of NE on
attentional processes. We highlight, in particular, the impact of the
context on its eﬀect on attentional processes. We also pinpoint its
complex mechanism of action on spatial attention, exerted at diﬀerent
levels, likely reﬂecting changes within sensory cortex leading to faster
accumulation rate to incoming stimuli as well as the adjustment of the
decisional threshold via an action of NE within prefrontal regions
(Robbins and Arnsten, 2009; Arnsten, 2011; Arnsten and Pliszka, 2011).
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